10-12 April 2018
Boston, MA, USA

About NASH Summit

Join Your Peers at the Forefront of Non-alcoholic Steatohepatitis Research

Focussed on Non-Alcoholic Steatohepatitis (NASH), the 2nd NASH Summit will bring together drug developers to solve the challenges they face from drug discovery to late stage clinical development.

Across 3 jam-packed days the brightest minds join the brightest-minds at this summit to discuss the datainsight and lessons learned enabling you to:

  • Optimize recapitulation of human NASHin vivo and effectively translate into the clinic
  • Validate non-invasive biomarker approaches and technologies to more robustly diagnose and track disease progression
  • Improve drug efficacy in both early and late stage NASH by identifying and validating novel targets & drug mechanisms of action
  • Define clinical primary and secondary endpoints and road-map your regulatory path to approval

Join your peers in Boston to overcome the challenges that are preventing you from accelerating the development of your NASH candidate.